Ticker >

Sanjivani Paranteral share price

Sanjivani Paranteral Ltd.

BSE: 531569 SECTOR: Pharmaceuticals & Drugs  8106   12   0

187.50
+1.70 (0.91%)
BSE: Today, 12:14 PM

Price Summary

Today's High

₹ 191.85

Today's Low

₹ 186.1

52 Week High

₹ 204.95

52 Week Low

₹ 51.3

FinStar

Ownership Below Par
Stock price may face volatility due to ownership structure.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

219.08 Cr.

Enterprise Value

221.27 Cr.

No. of Shares

1.17 Cr.

P/E

37.12

P/B

8.9

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  21.06

CASH

0.3 Cr.

DEBT

2.49 Cr.

Promoter Holding

27.67 %

EPS (TTM)

₹  5.05

Sales Growth

15.94%

ROE

0 %

ROCE

0%

Profit Growth

-6.91 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year15.94%
3 Year29.46%
5 Year14.6%

Profit Growth

1 Year-6.91%
3 Year66.8%
5 Year15.83%

ROE%

1 Year0%
3 Year0%
5 Year0%

ROCE %

1 Year0%
3 Year88.81%
5 Year0.09%

Debt/Equity

-0.8119

Price to Cash Flow

46.77

Interest Cover Ratio

14.7848596647209

CFO/PAT (5 Yr. Avg.)

2.29814780201032

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2024 27.67 0
Dec 2023 32.34 0
Sep 2023 32.34 0
Jun 2023 31.7 0
Mar 2023 29.88 0
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 66.8032121616451% for the Past 3 years.
  • The company has shown a good revenue growth of 29.4641647287873% for the Past 3 years.
  • The company has significantly decreased its debt by 3.4998495 Cr.
  • Company has a healthy Interest coverage ratio of 14.7848596647209.
  • The company has an efficient Cash Conversion Cycle of -175.519036617321 days.
  • The company has a good cash flow management; CFO/PAT stands at 2.29814780201032.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 5.04903657045223.

 Limitations

  • Company has a poor ROE of 0% over the past 3 years.
  • Company has contingent liabilities of 8.4118959 Cr.
  • Tax rate is low at 8.75358206291551.
  • The company has negative book value.

Quarterly Result (All Figures in Cr.)

PARTICULARS Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
Net Sales 9.12 8.12 12.58 14 14.96
Total Expenditure 8.2 6.7 10.57 11.89 13
Operating Profit 0.92 1.43 2.01 2.11 1.96
Other Income 0.31 -0.04 0.06 0.15 0.25
Interest 0.05 0.16 0.04 0.05 0.08
Depreciation 0.23 0.23 0.23 0.23 0.24
Exceptional Items 0 0 0 0 0
Profit Before Tax 0.95 1 1.8 1.99 1.9
Tax 0 0 0.25 0.28 0.25
Profit After Tax 0.95 1 1.55 1.71 1.65
Adjusted EPS (Rs) 0.95 1 1.55 1.71 1.65

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Net Sales 25.09 16.36 25.1 30.61 35.49
Total Expenditure 26.85 16.91 22.96 26.36 30.24
Operating Profit -1.76 -0.55 2.14 4.25 5.25
Other Income 0.96 0.47 0.26 1.72 0.94
Interest 0.33 0.66 0.13 0.21 0.36
Depreciation 1.17 1.07 0.86 0.88 0.89
Exceptional Items 0 0 0 0 0
Profit Before Tax -2.3 -1.81 1.41 4.88 4.94
Tax -0.23 -0.1 -0.01 0.03 0.43
Net Profit -2.07 -1.71 1.42 4.85 4.51
Adjusted EPS (Rs.) -3.5 -2.9 1.67 4.85 4.51

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Equity and Liabilities
Share Capital 5.9 5.9 8.5 10 10
Total Reserves -53.1 -54.81 -53.39 -17.58 -13.07
Borrowings 8.13 7.95 5.3 2.75 0.76
Other N/C liabilities 1.38 1.22 1.24 1.24 0.67
Current liabilities 55.67 55.4 57.63 21.89 22.65
Total Liabilities 17.97 15.66 19.28 18.3 21.01
Assets
Net Block 8.99 8.04 7.62 7.42 7.57
Capital WIP 0 0 0 0 0
Intangible WIP 0 0 0 0 0
Investments 0.05 0.05 0.05 0.05 0.05
Loans & Advances 2.1 3.72 2.38 3.1 5.11
Other N/C Assets 0.05 0.05 0.05 0 0.01
Current Assets 6.78 3.79 9.18 7.73 8.27
Total Assets 17.97 15.66 19.28 18.3 21.01
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Profit from operations -2.3 -1.81 1.41 4.88 4.94
Adjustment 1.32 1.56 1.36 -0.52 0.68
Changes in Assets & Liabilities 3.49 0.08 -2.16 4.22 -0.9
Tax Paid -0.03 -0.01 -0.03 -0.05 -0.04
Operating Cash Flow 2.48 -0.17 0.58 8.52 4.68
Investing Cash Flow 0.02 -0.12 -0.42 -0.67 -0.99
Financing Cash Flow -2.3 0.33 -0.26 -7.68 -3.73
Net Cash Flow 0.2 0.03 -0.09 0.17 -0.04

Corporate Actions

Investors Details

PARTICULARS Mar 2023% Jun 2023% Sep 2023% Dec 2023% Mar 2024%
promoters 29.88 31.70 32.34 32.34 27.67
ashwani khemka 27.81 29.63 30.26 30.26 25.90
naina khemka 2.07 2.07 2.07 2.07 1.78
PARTICULARS Mar 2023% Jun 2023% Sep 2023% Dec 2023% Mar 2024%
investors 70.12 68.30 67.66 67.66 72.33
ashish kacholia - - - - 3.17
india equity fund 1 - - - - 5.14
kanta suresh jain . - - - - 7.17
monika garware - - - - 2.57
next orbit ventures fund 14.23 11.89 8.16 6.01 4.57
sun capital advisory serv... 4.65 5.02 5.00 5.00 4.28
suresh pukhraj jain . - - - - 7.17
usha ravindra bhat 2.70 2.70 2.70 2.05 2.00
kanta suresh jain 9.01 9.01 7.41 8.00 -
llp 0.02 0.01 0.10 0.40 -
rajesh chimanlal jogani... - - - 1.08 -
setu securities private l... - - - 1.28 -
suresh pukhraj jain 6.11 7.93 8.15 8.00 -
surekha haran - - 1.01 - -
suncap ss global ventures... 1.45 - - - -

Annual Reports

Ratings & Research Reports

Company Presentations

Company News

Sanjivani Paranteral informs about outcome of board meeting8 Apr 2024, 3:16PM Sanjivani Paranteral incorporates subsidiary company 28 Feb 2024, 6:33PM Sanjivani Paranteral informs about audio recording of investors meet 13 Feb 2024, 11:38AM Sanjivani Paranteral informs about press release 12 Feb 2024, 1:10PM Sanjivani Paranteral informs about investor presentation12 Feb 2024, 1:04PM Sanjivani Paranteral - Quaterly Results5 Feb 2024, 1:44PM Sanjivani Paranteral - Quaterly Results5 Feb 2024, 1:44PM Sanjivani Paranteral - Quaterly Results5 Feb 2024, 1:44PM Sanjivani Paranteral informs about EGM outcome18 Jan 2024, 3:27PM Sanjivani Paranteral informs about compliances-certificate10 Jan 2024, 1:21PM Sanjivani Paranteral informs about press release26 Dec 2023, 4:41PM Sanjivani Paranteral informs about closure of trading window19 Dec 2023, 1:45PM Sanjivani Paranteral informs about revised investor presentation22 Nov 2023, 12:19PM Sanjivani Paranteral informs about newspaper publication23 Oct 2023, 12:19PM Sanjivani Paranteral informs about investor presentation19 Oct 2023, 12:36PM Sanjivani Paranteral informs about revised press release19 Oct 2023, 10:49AM Sanjivani Paranteral - Quaterly Results18 Oct 2023, 2:44PM Sanjivani Paranteral - Quaterly Results18 Oct 2023, 2:44PM Sanjivani Paranteral - Quaterly Results18 Oct 2023, 2:44PM Sanjivani Paranteral inks pact with Hindustan Antibiotics2 Aug 2023, 3:15PM Sanjivani Paranteral informs about outcome of board meeting24 Jul 2023, 4:17PM Sanjivani Paranteral - Quaterly Results24 Jul 2023, 3:15PM Sanjivani Paranteral - Quaterly Results24 Jul 2023, 3:15PM Sanjivani Paranteral - Quaterly Results24 Jul 2023, 3:15PM Sanjivani Paranteral informs about certificate11 Jul 2023, 1:02PM Sanjivani Paranteral informs about disclosure19 Jun 2023, 1:48PM Sanjivani Paranteral informs about disclosure17 Jun 2023, 3:10PM Sanjivani Paranteral informs about disclosure 8 Jun 2023, 12:20PM Sanjivani Paranteral informs about newspaper publication9 May 2023, 5:21PM Sanjivani Paranteral enters into partnership with Aievia Helathcare9 May 2023, 3:49PM Sanjivani Paranteral informs about outcome of board meeting6 May 2023, 2:33PM Sanjivani Paranteral - Quaterly Results6 May 2023, 1:44PM Sanjivani Paranteral - Quaterly Results6 May 2023, 1:44PM Sanjivani Paranteral - Quaterly Results6 May 2023, 1:44PM Sanjivani Paranteral informs about disclosure1 Apr 2023, 1:01PM Sanjivani Paranteral informs about disclosure27 Mar 2023, 4:29PM Sanjivani Paranteral informs about disclosure14 Mar 2023, 3:01PM Sanjivani Paranteral - Quaterly Results14 Feb 2023, 12:47PM Sanjivani Paranteral informs about board meeting5 Nov 2022, 2:22PM Sanjivani Paranteral - Quaterly Results8 Aug 2022, 4:02PM Sanjivani Paranteral - Quaterly Results8 Aug 2022, 4:02PM Sanjivani Paranteral informs about closure of trading window2 Jul 2022, 11:41AM Sanjivani Paranteral - Quaterly Results17 May 2022, 5:33PM Sanjivani Paranteral - Quaterly Results17 May 2022, 5:33PM Sanjivani Paranteral informs about changes in board composition24 Mar 2022, 3:58PM Sanjivani Paranteral informs about un-audited financial results14 Feb 2022, 4:23PM Sanjivani Paranteral informs about trading window closure12 Oct 2021, 12:44PM Sanjivani Paranteral informs about disclosures 20 Aug 2021, 2:00PM Sanjivani Paranteral informs about outcome of board meeting20 Aug 2021, 9:39AM Sanjivani Paranteral informs about proceedings of the EGM27 Jul 2021, 12:23PM

Sanjivani Paranteral Stock Price Analysis and Quick Research Report. Is Sanjivani Paranteral an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Sanjivani Paranteral and its performance over the period of time.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Sanjivani Paranteral cash from the operating activity was Rs 4.6843926 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Sanjivani Paranteral has a Debt to Equity ratio of -0.8119 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Sanjivani Paranteral , the EPS growth was -6.9091434230071 % which is bad for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Sanjivani Paranteral has OPM of 14.7927843281055 % which is a bad sign for profitability.
     
  • ROE: Sanjivani Paranteral have a poor ROE of 0 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Sanjivani Paranteral is Rs 189. One can use valuation calculators of ticker to know if Sanjivani Paranteral share price is undervalued or overvalued.
Last Updated on:
Brief about Sanjivani Paranteral
X